Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1992-03-24
1993-06-08
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 3116
Patent
active
052179990
ABSTRACT:
A method of inhibiting cell proliferation in a patient suffering from such disorder comprising administering to said patient an effective amount of a composition comprising, in admixture with a pharmaceutically acceptable carrier, a compound, or a pharmaceutically acceptable salt thereof, which is a substituted styrene compound which can also be a naphthalene, an indane or a benzoxazine; including nitrile and molononitrile compounds, and pharmaceutical compositions comprising, in admixture with a pharmaceutically acceptable carrier, a pharmaceutically-effective amount of such compound.
REFERENCES:
patent: 3149148 (1964-09-01), Kladko et al.
patent: 3527785 (1970-09-01), Ozaki et al.
patent: 4064266 (1977-12-01), Birchall et al.
Chem. Abst. 111-187005f (1989).
P. Yaish, A. Gazit, C. Gilon and A. Levitzki, Science, 242, pp. 933-935 (. 11, 1988).
A. Gazit, P. Yaish, C. Gilon and A. Levitzki, J. Med. Chem., 32, pp. 2344-2352 (Oct. 1989).
T. Shiraishi, K. Kameyama, N. Imai, T. Domoto, I. Katsumi and K. Watanabe, Chem. Pharm. Bull., 36(3) pp. 974-981 (1988).
T. Shiraishi, T. Domoto, N. Imai, Y. Shimada and K. Watanabe, Biochemical and Bioplysical Research Communications, 147(1), pp. 322-328 (Aug. 31, 1987).
E. M. Gal, F. Fung and D. M. Greenberg, Cancer Research, vol. 12, pp. 565-572 (1952).
I. Katsumi, Chem. Pharm. Bull., vol. 34(4), pp. 1619-1627.
E. Gal, F. Fung and D. Greenberg, Cancer Research, vol. 12, pp. 574-579 (1952).
Chorev Michael
Gazit Aviv
Gilon Chaim
Levitzki Alexander
Friedman S. J.
Yissum Research Development Company of the Hebrew University of
LandOfFree
Styryl compounds which inhibit EGF receptor protein tyrosine kin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Styryl compounds which inhibit EGF receptor protein tyrosine kin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Styryl compounds which inhibit EGF receptor protein tyrosine kin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934377